The development of HCC in hepatitis B virus (HBV)-infected patients, for example, involves dysregulation in p53, PI3K, TGF-β, IL-6, VEGF, and TERT pathways 17, 18, thereby acquiring oncogenic hallmarks for HCC development (Table S5). The gene discussed is VEGFA; the disease is hepatocellular carcinoma.